(Q40864858)

English

A HER2/NEU-derived peptide, a K(d)-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8(+) cytotoxic T lymphocytes

scientific article published on August 2000

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

A HER2/NEU-derived peptide, a K(d)-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8(+) cytotoxic T lymphocytes (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

author name string

Y Ikuta

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

T Okugawa

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

R Furugen

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Y Nagata

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Y Takahashi

5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

L Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

H Ikeda

7

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

M Watanabe

8

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

S Imai

9

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

H Shiku

10

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

language of work or name

0 references

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

87

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

553-558

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

DNA typing of the HLA-A gene: population study and identification of four new alleles in Japanese

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

Evolution of the proteasome components

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

T cell defined tumor antigens

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

Selection of highly transfectable variant from mouse mastocytoma P815.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

A novel ex vivo method for assaying adhesion of cancer cells to the peritoneum

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

The c-erb B-2 proto-oncogene in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

HLA-B51 transgenic mice as recipients for production of polymorphic HLA-A, B-specific antibodies

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000815%2987%3A4%3C553%3A%3AAID-IJC15%3E3.0.CO%3B2-8

21 January 2018

Identifiers

10.1002/1097-0215(20000815)87:4<553::AID-IJC15>3.0.CO;2-8

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40864858&oldid=1909321469"